CD24 and breast carcinoma: Breast cancer was the first human solid tumor proven to consist of heterogeneous populations of cells: non-CSCs and CSCs; specifically the CSCs subpopulation (CD44+ CD24−/low) is capable of initiating tumor growth in immune-deficient mice [27].